Convalescent Plasma Collection and Treatment in Pediatrics and Adults

Summary

This is a prospective study, using plasma to help fight off infections of those suffering from COVID-19 in accordance with collection guidelines for plasma and FDA IND requirements. This study included up to 240 participants potentially receiving convalescent plasma. NOTE: West Virginia does not have any entity with the required FDA registration/licensure or necessary equipment to collect convalescent plasma for transfusion. Therefore, the plasma donation portion of this study was not completed.

Timeline

Start

2020-04-16

Primary completion

2021-02-28

Completion

2021-04-21

Drugs

Indications